Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

NCT01712100 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan
DRUG: Avapro

Sponsor

Roxane Laboratories